Peritoneal Serous Carcinoma

About
Mappings

OncoTree: Peritoneal Serous Carcinoma (coding:oncotree:PSEC)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organizations Biomarkers Cancer types Therapies
FDA (1) BRCA1 pathogenic variants Peritoneal Serous Carcinoma Niraparib
FDA (1) BRCA2 pathogenic variants Peritoneal Serous Carcinoma Niraparib
FDA (2) HC (1) BRCA1 oncogenic variants Peritoneal Serous Carcinoma Olaparib
FDA (2) HC (1) BRCA1 pathogenic variants Peritoneal Serous Carcinoma Olaparib
FDA (2) HC (1) BRCA2 oncogenic variants Peritoneal Serous Carcinoma Olaparib
FDA (2) HC (1) BRCA2 pathogenic variants Peritoneal Serous Carcinoma Olaparib
FDA (1) HC (1) BRCA1 oncogenic variants Peritoneal Serous Carcinoma Bevacizumab, Olaparib
FDA (1) HC (1) BRCA1 pathogenic variants Peritoneal Serous Carcinoma Bevacizumab, Olaparib
FDA (1) HC (1) BRCA2 oncogenic variants Peritoneal Serous Carcinoma Bevacizumab, Olaparib
FDA (1) HC (1) BRCA2 pathogenic variants Peritoneal Serous Carcinoma Bevacizumab, Olaparib
FDA (1) HRD Peritoneal Serous Carcinoma Bevacizumab, Olaparib
FDA (1) BRCA1 oncogenic variants Peritoneal Serous Carcinoma Rucaparib
FDA (1) BRCA1 pathogenic variants Peritoneal Serous Carcinoma Rucaparib
FDA (1) BRCA2 oncogenic variants Peritoneal Serous Carcinoma Rucaparib
FDA (1) BRCA2 pathogenic variants Peritoneal Serous Carcinoma Rucaparib
FDA (1) FOLR1 positive Peritoneal Serous Carcinoma Mirvetuximab soravtansine
FDA (1) PD-L1 (CPS) >= 1 Peritoneal Serous Carcinoma Paclitaxel, Pembrolizumab
FDA (1) PD-L1 (CPS) >= 1 Peritoneal Serous Carcinoma Bevacizumab, Paclitaxel, Pembrolizumab